CEA Valorisation, a 100% CEA (French Atomic Energy Commission) subsidiary with a capital of 27 million euros, will be celebrating its tenth anniversary in 2009. Specialized in launching and funding businesses working with CEA technologies, CEA Valorisation has just financed the startup of three businesses, Sun Land 21, Cytoo, and Eye Tech Care, in a range of industries (energy/environment, biotechnologies, and medical equipment). At the same time as the startup operations, CEA Valorisation has just deployed its first two projects funded under the SEMPRIN system that finances emerging projects. This means that CEA Valorisation has a very original and complete tool for support to technological startups.
Sun Land 21 engineers roof components that integrate photovoltaic modules directly, thus advancing the renewable energy industry. Cytoo has taken innovations from CEA and the Curie Institute to work on the design of products slated to revolutionize the practice of cellular analysis. Eye Tech Care with help from an INSERM team has developed a revolutionary ultrasound-based procedure for treating eye diseases. The technique, which will soon be undergoing animal trials, should eventually lead to the design of equipment for hospital and ophthalmologists.
